Effect of Simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S)

American Journal of Cardiology

Volumn 81, Issue 3, 1998, Pages 333-335

  Pedersen, Terje R ^a   Kjekshus, John ^b   Pyörälä, Kalevi ^b   Olsson, Anders G ^b   Cook, Thomas J ^b   Musliner, Thomas A ^b   Tobert, Jonathan A ^b   Haghfelt, Torben ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; PLACEBO; SIMVASTATIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY BRUIT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCANDINAVIA; SURVIVAL;

ADULT; AGED; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; DISEASE PROGRESSION; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; SIMVASTATIN; TREATMENT OUTCOME;

EID: 0032006859     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00904-1     Document Type: Article

References (14)

1. Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Sanmarco ME, Selzer RH, Shircore AM, Wickham EC. Effects of colestipol-niacin therapy on human femoral atherosclerosis. Circulation. 83:1991;438-447.
2. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, Pearce MB, Yellin AE, Edminston WA, Smink RD, Sawin HS, Campos CT, Hansen BJ, Tuna N, Karnegis JN, Sanmarco ME, Amplatz K, Castaneda-Zuniga WR, Hunter DW, Bissett JK, Weber FJ, Stevenson JW, Leon AS, Chalmers TC. Effect of partial ileal bypass on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia - report of the Program on the Surgical Control of Hyperlipidemias (POSCH). N Engl J Med. 323:1990;946-955.
3. Walldius G, Erikson U, Olsson AG, Bergstrand L, Hådell K, Johansson J, Kaijser L, Lassvik C, Mölgaard J, Nilsson S, Schäfer-Elinder L, Steneport G, Holme I. The effect of probucol on femoral atherosclerosis the Probucol Quantitative Regression Swedish Trial (PQRST) . Am J Cardiol. 74:1994;875-883.
4. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) . Lancet. 344:1994;1383-1389.
5. The Lipid Research Clinics Coronary Primary Prevention Trial Results. JAMA. 251:1984;351-374.
6. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 335:1996;1001-1009.
7. Furberg CD, Adams HP Jr, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA, Young B. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation. 90:1994;1679-1687.
8. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, Park J-S, Salonen JT. Kuopio Atherosclerosis Prevention Study (KAPS) A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries . Circulation. 92:1995;1758-1764.
9. Mölgaard J, von Schenck H, Kuusi T, Holme I, Lassvik C, Taskinen M-R, Olsson AG. Plasma lipoprotein abnormalities and apolipoprotein E phenotypes in intermittent claudication A multivariate analysis of randomly selected subjects . Nutr Metab Cardiovasc Dis. 6:1996;114-123.
10. Cholesterol, diastolic blood pressure, and stroke 13,000 strokes in 450,000 people in 45 prospective cohorts . Lancet. 346:1995;1647-1653.
11. Atkins D, Psaty B, Koepsell T, Longstreth WJ, Larson E. Cholesterol reduction and the risk for stroke in men a meta-analysis of randomized, controlled trials . Ann Intern Med. 119:1993;136-145.
12. Crouse JR III, Byington RP, Hoen HM, Furberg CD. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med. 157:1997;1305-1310.
13. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality An overview of randomized trials . JAMA. 278:1997;313-321.
14. Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Am J Cardiol. 75:1995;1130-1134.